| T8 Influenza: From Correlates of Protection to Next Generation Vaccines |  |  |  | Florian Krammer, Aubree Gordon and Davide Corti |  | Jan 1 - 4 | 
              
    
            
            
              | Y3 Biomolecular Condensates: Phase-Separated Organizers of Cellular Biochemistry |  |  |  | J. Paul Taylor and Geraldine Seydoux |  | Jan 1 - 4 | 
              
    
            
            
              | Y4 Neuronal Cell Biology: A Biology of Extremes |  |  |  | Timothy A. Ryan and Erin M. Schuman |  | Jan 1 - 4 | 
              
    
            
            
              | F1 Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment | May. 25 | May. 25 | Jun. 28 | Steven G Deeks, Michael J. Holtzman, Resia Pretorius and Catherine A. Blish |  | Aug 27 - 30 | 
              
    
            
            
              | F2 Transposable Elements at the Crossroads of Evolution, Health and Disease | Jun. 1 | Jun. 1 | Jul. 6 | Kathleen H. Burns, Harmit S. Malik and Irina Arkhipova |  | Sep 3 - 6 | 
              
    
            
            
              | EK1 Next-Generation Nanomedicine |  | Aug. 30 |  | Philip L. Felgner, Anna K. Blakney and Norbert Pardi |  | Sep 6 - 8 | 
              
    
            
            
              | F6 Vaccinology During and After COVID-19 | Jun. 15 | Jun. 15 | Jul. 19 | Bali Pulendran, Robert A. Seder and Gagandeep Kang |  | Sep 17 - 20 | 
              
    
            
            
              | F3 Immunity and Aging | Jun. 28 | Jun. 28 | Aug. 1 | Danica Chen, Sun Hur and Joan Mannick |  | Oct 1 - 4 | 
              
    
            
            
              | G5 Cilia in Development and Disease |  |  |  | Maxence V. Nachury, Piali Sengupta and Gaia Pigino |  | Oct 1 - 4 | 
              
    
            
            
              | H4 Vaccinology |  |  |  |  |  | Oct 1 - 4 | 
              
    
            
            
              | J1 B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics | Jun. 28 | Jun. 28 | Aug. 1 | Tullia C. Bruno, Brad H. Nelson, Daniel Hollern and Marie-Caroline Dieu-Nosjean |  | Oct 1 - 4 | 
              
    
            
            
              | J2 T and B Cell Collaboration in Germinal Centers and Beyond | Jun. 28 | Jun. 28 | Aug. 1 | Shane Crotty, Michela Locci and Jennifer L. Gommerman |  | Oct 1 - 4 | 
              
    
            
            
              | J3 Circulating Metabolic Intermediates as Fuels and Signals | Jul. 6 | Jul. 6 | Aug. 8 | Sven Enerbäck, Joshua D. Rabinowitz and Sarah-Maria Fendt |  | Oct 8 - 11 | 
              
    
            
            
              | J4 Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade | Jul. 6 | Jul. 6 | Aug. 8 | Jorge Henao-Mejia, Eran Elinav and Lora V. Hooper |  | Oct 8 - 11 | 
              
    
            
            
              | F4 COVID-19 and the World Response: Are We Prepared for the Next Pandemic? |  |  |  | Nevan J. Krogan, Ana Fernandez-Sesma, John A. T. Young and Jacqueline M. Fabius |  | Nov 12 - 16 | 
              
    
            
            
              | J5 Autophagy and Disease | Aug. 30 | Aug. 30 | Oct. 3 | Eric H. Baehrecke and Anastasia Henry |  | Dec 3 - 6 | 
              
    
            
            
              | J6 Ubiquitin Biology and Disease | Aug. 30 | Aug. 30 | Oct. 3 | Ivan Dikic and Cynthia Wolberger |  | Dec 3 - 6 | 
              
    
            
            
              | J7 RNA Modifications in Health and Disease | Sep. 7 | Sep. 25 | Oct. 12 | Eric A. Miska, Ramesh S. Pillai and Eva Maria Novoa Pardo |  | Dec 12 - 15 | 
              
    
            
            
              | J8 Regulatory RNAs: Emerging Mechanisms | Sep. 7 | Sep. 25 | Oct. 12 | Mitchell Guttman, Phillip D. Zamore and Maite Huarte |  | Dec 12 - 15 | 
              
    
            
            
              | G8 Next-Generation Therapeutic Development in Inflammatory Bowel Disease |  |  |  | Dermot P. B. McGovern, Séverine Vermeire, Ailsa Hart and Thaddeus S. Stappenbeck |  | Jan 1 - 4 | 
              
    
            
            
              | H8 Neuropsychiatric and Neurodevelopmental Disorders: Harnessing Rare Variants |  |  |  | Jennifer G. Mulle, Audrey Thurm, Christa L. Martin and Carrie E. Bearden |  | Jan 1 - 4 | 
              
    
            
            
              | W7 Eukaryotic Gene Regulation: New Mechanisms and Technologies |  |  |  | Shannon M. Lauberth, Lu Bai and Laura A. Banaszynski |  | Jan 1 - 4 | 
              
    
            
            
              | Q1 Exercise Biology: Signaling, Mechanisms and Benefits | Oct. 24 | Oct. 24 | Nov. 14 | Jeffrey F. Horowitz, Laurie J. Goodyear and Karyn A. Esser |  | Jan 14 - 17 | 
              
    
            
            
              | Q2 Mammalian Somatosensation: Mechanisms of Itch, Touch, Pain and Interoception in Health and Disease | Oct. 24 | Oct. 24 | Nov. 14 | Diana Bautista, Rebecca P. Seal and Ishmail John Abdus-Saboor |  | Jan 14 - 17 | 
              
    
            
            
              | A1 Inhibitory Receptors in Immune Homeostasis, Disease and Therapy | Oct. 25 | Oct. 25 | Nov. 16 | Linde Meyaard, Jonathon D. Sedgwick, Carla V. Rothlin and Alex McCarthy |  | Jan 16 - 19 | 
              
    
            
            
              | A2 Single-Cell Biology: Tissue Genomics, Technologies and Disease | Oct. 26 | Oct. 26 | Nov. 16 | Jason Buenrostro, Lacramioara Bintu and Fei Chen |  | Jan 21 - 24 | 
              
    
            
            
              | Q3 Targeted Protein Degradation | Oct. 26 | Oct. 26 | Nov. 16 | James E. Bradner, Eric S. Fischer and Brenda A. Schulman |  | Jan 21 - 24 | 
              
    
            
            
              | Q4 Proximity Based Therapeutics | Oct. 26 | Oct. 26 | Nov. 16 | Ryan Potts and Michelle R. Arkin |  | Jan 21 - 24 | 
              
    
            
            
              | Q5 Emerging Cellular Therapies | Oct. 30 | Oct. 30 | Nov. 21 | Dan S. Kaufman,  Kiem and Sonja Schrepfer |  | Jan 22 - 25 | 
              
    
            
            
              | Q6 Stem Cells and Regeneration | Oct. 30 | Oct. 30 | Nov. 21 | Heinrich Jasper and Emmanuelle Passegué |  | Jan 22 - 25 | 
              
    
            
            
              | Q7 Delivery of Nucleic Acid Therapeutics | Nov. 3 | Nov. 3 | Nov. 22 | Daniel J. Siegwart and Kathryn Whitehead |  | Jan 22 - 25 | 
              
    
            
            
              | Q8 Precision Genome Engineering | Nov. 2 | Nov. 2 | Nov. 21 | Morgan Maeder, Benjamin P. Kleinstiver and Kiran Musunuru |  | Jan 22 - 25 | 
              
    
            
            
              | A3 Myeloid Cell Diversity: From Fundamental Biology to Disease States | Oct. 24 | Oct. 24 | Nov. 28 | Andrés Hidalgo, Daniela F. Quail and Lai Guan Ng |  | Jan 28 - 31 | 
              
    
            
            
              | B1 Epigenetic Mechanisms and Cancer Treatment | Oct. 31 | Oct. 31 | Dec. 5 | Tony Kouzarides, Rab K. Prinjha and Marisa S. Bartolomei |  | Feb 4 - 7 | 
              
    
            
            
              | X3 Cardiometabolic Diseases: The Role of Ethnic Diversity in Precision Medicine | Dec. 1 | Dec. 6 | Dec. 6 | Paul W. Franks, Ewan Pearson and Karin Conde-Knape |  | Feb 4 - 7 | 
              
    
            
            
              | X4 Obesity Causes and Consequences | Oct. 31 | Oct. 31 | Dec. 5 | Giles S.H. Yeo, Karine Clément and Murielle M. Véniant-Ellison |  | Feb 4 - 7 | 
              
    
            
            
              | T4 Stem Cell Models for Embryology | Nov. 2 | Nov. 22 | Dec. 7 | Aryeh Warmflash and Magdalena D. Zernicka-Goetz |  | Feb 6 - 8 | 
              
    
            
            
              | B2 Systemic Autoimmune and Autoinflammatory Diseases | Nov. 1 | Nov. 21 | Dec. 7 | Mariana J. Kaplan, Georg Schett and Carola G. Vinuesa |  | Feb 8 - 11 | 
              
    
            
            
              | T1 CANCELLED: Neurobiology of Reward and Addiction | Nov. 30 | Nov. 30 | Dec. 12 | Thomas Kash, Camilla Bellone, Michael Taffe and Ziva Cooper |  | Feb 12 - 14 | 
              
    
            
            
              | B3 Tumor Metabolism | Nov. 7 | Nov. 7 | Dec. 12 | Gina DeNicola, Rushika M. Perera and David B. Shackelford |  | Feb 12 - 15 | 
              
    
            
            
              | X5 Mitochondria Signaling and Disease | Nov. 8 | Nov. 8 | Dec. 13 | Heidi M. McBride and Timothy Wai |  | Feb 12 - 15 | 
              
    
            
            
              | X6 Organelle Membrane Contact Sites in Health and Disease | Nov. 29 | Nov. 29 | Dec. 14 | Gia K. Voeltz and Jodi Nunnari |  | Feb 12 - 15 | 
              
    
            
            
              | X7 Fungal Pathogens: Emerging Threats and Future Challenges | Nov. 9 | Nov. 9 | Dec. 14 | Michail Lionakis, Sarah L. Gaffen and Mari L. Shinohara |  | Feb 18 - 21 | 
              
    
            
            
              | X8 Regulation of Barrier Immunity | Nov. 10 | Nov. 10 | Dec. 15 | David Artis, Yasmine Belkaid, Fiona M. Powrie and Kenya Honda |  | Feb 18 - 21 | 
              
    
            
            
              | B4 Hematopoiesis | Nov. 29 | Nov. 29 | Dec. 19 | Trista E. North, Michael G. Kharas and Nina Cabezas-Wallscheid |  | Feb 25 - 28 | 
              
    
            
            
              | C1 MASH and Fibrosis: From Molecular Phenotypes to Precision Therapeutics | Nov. 28 | Dec. 14 | Jan. 4 | Stefano Romeo, Michael Charlton, Silvia C. Sookoian and Gregory Tesz |  | Mar 3 - 6 | 
              
    
            
            
              | T2 Unraveling Vascular Layers to Understand Human Disease | Jan. 2 | Jan. 2 | Jan. 16 | Rachel J. Roth Flach and Stephanie Wengert Watts |  | Mar 17 - 19 | 
              
    
            
            
              | C2 Cancer Immunotherapy: Beyond Immune Checkpoint Blockade and Overcoming Resistance | Dec. 7 | Dec. 7 | Jan. 17 | James P. Allison, Andrea Schietinger, Antoni Ribas and Padmanee Sharma |  | Mar 17 - 20 | 
              
    
            
            
              | K2 Microbiota and Cancer Immunity | Dec. 26 | Dec. 26 | Jan. 17 | Giorgio Trinchieri, Jenny P.Y. Ting, Hsing-Jien Kung and Shie-Liang Hsieh |  | Mar 17 - 20 | 
              
    
            
            
              | C3 Immunometabolism: From Mechanisms to Pathways to Therapies | Dec. 7 | Dec. 7 | Jan. 17 | Luke A. J. O'Neill, Evanna Mills and Erika L. Pearce |  | Mar 18 - 21 | 
              
    
            
            
              | C4 Tuberculosis: The Host-Pathogen Interface | Dec. 19 | Dec. 19 | Jan. 24 | Marcel A. Behr, Lalita Ramakrishnan and Kevin B. Urdahl |  | Mar 24 - 27 | 
              
    
            
            
              | K1 HIV and (Re)Emerging Viruses: Aligning Lessons Across Pandemics | Jan. 17 | Jan. 17 | Feb. 7 | Melanie M. Ott, Priti Kumar, Olivier Schwartz and Alex Sigal |  | Apr 8 - 11 | 
              
    
            
            
              | Z1 Innate Immunity Across the Molecular, Cellular, Tissue and Therapeutic | Jan. 18 | Jan. 18 | Feb. 8 | Kate L. Jeffrey, Ramnik Xavier and Xu Zhou |  | Apr 9 - 12 | 
              
    
            
            
              | Z2 Systems and Engineering Immunology: Advancing Immunological Insights in Health and Disease | Jan. 18 | Jan. 18 | Feb. 8 | John Tsang, Shannon J Turley and Alex Marson |  | Apr 9 - 12 | 
              
    
            
            
              | C5 Cardiovascular Epigenetics and Gene Regulation | Jan. 23 | Jan. 23 | Feb. 14 | Roger Foo, Federica Accornero and Enzo R. Porrello |  | Apr 15 - 18 | 
              
    
            
            
              | EK2 AI in Biomedicine |  | Mar. 20 |  | Thomas Hartung, Weida Tong and Yvonne Will |  | May 1 - 3 | 
              
    
            
            
              | T3 Cachexia and Wasting Syndrome in Cancer and Chronic Diseases | Feb. 14 | Feb. 14 | Mar. 5 | Bei B. Zhang and Teresa Zimmers |  | May 5 - 7 | 
              
    
            
            
              | C6 Antibodies as Drugs: The Art in Antibody Engineering | Feb. 13 | Feb. 13 | Mar. 5 | Laura M. Walker and Paul W. H. I. Parren |  | May 5 - 8 | 
              
    
            
            
              | C7 Myeloid Targeting Strategies for Cancer Treatment | Jan. 31 | Jan. 31 | Mar. 6 | Miriam Merad and Matthew F. Krummel |  | May 6 - 9 | 
              
    
            
            
              | Z3 Neurodegenerative Diseases | Feb. 29 | Feb. 29 | Apr. 4 | Leonard Petrucelli, Stacie Weninger and Soyon Hong |  | Jun 3 - 6 | 
              
    
            
            
              | Z4 Neuroimmune Interactions: Nervous System and Immune Cell Heterogeneity in Health and Disease | Feb. 29 | Feb. 29 | Apr. 4 | Nicola J. Allen, Anna Victoria Molofsky and Francisco J. Quintana |  | Jun 3 - 6 |